Bafna Pharmaceuticals Limited has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be closed for all designated persons and their immediate relatives starting from January 01, 2026. It will remain closed until 48 hours after the declaration of the un-audited financial results for the third quarter ending December 31, 2025. Both the start and end dates are inclusive. Designated persons and their immediate relatives have been formally notified and are prohibited from trading in the company's securities during this period.